Status: current, Primitive. Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4011855016 | Fostemsavir | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4011856015 | Fostemsavir (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fostemsavir | Is a | Piperazine and/or piperazine derivative | true | Inferred relationship | Some | ||
| Fostemsavir | Has disposition | HIV fusion inhibitor | true | Inferred relationship | Some | ||
| Fostemsavir | Is a | Human immunodeficiency virus fusion inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fostemsavir-containing product | Has active ingredient | True | Fostemsavir | Inferred relationship | Some | 1 |
| Fostemsavir only product | Has active ingredient | True | Fostemsavir | Inferred relationship | Some | 1 |
| Fostemsavir-containing product in oral dose form | Has active ingredient | True | Fostemsavir | Inferred relationship | Some | 1 |
| Fostemsavir only product in oral dose form | Has active ingredient | True | Fostemsavir | Inferred relationship | Some | 1 |
| Fostemsavir 600 mg prolonged-release oral tablet | Has BoSS | True | Fostemsavir | Inferred relationship | Some | 1 |
| Fostemsavir 600 mg prolonged-release oral tablet | Has precise active ingredient | True | Fostemsavir | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR